دورية أكاديمية
أعرض في EDS

The Stiff Joint: Comparative Evaluation of Monotherapy and Combination Therapy With Urate Lowering Agents in Managing Acute Gout.

التفاصيل البيبلوغرافية
العنوان: The Stiff Joint: Comparative Evaluation of Monotherapy and Combination Therapy With Urate Lowering Agents in Managing Acute Gout.
المؤلفون: Okobi OE; Family Medicine, Larkin Community Hospital Palm Springs Campus, Miami, USA.; Family Medicine, Medficient Health Systems, Laurel, Maryland, USA.; Family Medicine, Lakeside Medical Center, Belle Glade, USA., Oletu H; Medicine and Surgery, University of Benin, Benin City, NGA.; Public Health, University of Wolverhampton, Wolverhampton, GBR., Chukwuedozie-Echeazu AB; General Practice, Ebonyi State University, Ebonyi, NGA.; General Practice, University of Lagos, Lagos, NGA., Keke VC; Internal Medicine, University of Nigeria, Enugu, NGA., Nwachukwu OB; Neurosciences and Psychology, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.; Family Medicine, American International School of Medicine Georgetown, Guyana, USA., Akunne HS; Internal Medicine, Delta State University, Abraka, NGA., Ekpemiro CU; Surgery, Federal Medical Centre, Umuahia, NGA., Oranika US; Family Medicine, University of Alberta Hospital, Edmonton, CAN., Akueme NT; Dermatology, University of Medical Sciences (UNIMEDTH), Ondo State, NGA., Akanle OE; General Practice, Nisa Premier Hospital, Abuja, NGA., Ogbuagu BC; Family Medicine, Deer Ridge Family Clinic (DRFC), Calgary, CAN., Mbah LA; Primary Care, Veterans Affairs, Fortwayne, USA.
المصدر: Cureus [Cureus] 2023 Sep 12; Vol. 15 (9), pp. e45087. Date of Electronic Publication: 2023 Sep 12 (Print Publication: 2023).
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Cureus, Inc Country of Publication: United States NLM ID: 101596737 Publication Model: eCollection Cited Medium: Print ISSN: 2168-8184 (Print) Linking ISSN: 21688184 NLM ISO Abbreviation: Cureus Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: Palo Alto, CA : Cureus, Inc.
مستخلص: Gout, an extremely painful form of arthritis, is triggered by the innate immune system's response to the accumulation of monosodium urate crystals in specific joints and surrounding tissues. This condition is characterized by recurring episodes of excruciating arthritis flares, interspersed with periods of disease quiescence. Over time, gout can result in disability, tophi formation, and severe pain. The treatment of gout is centered around two main objectives: alleviating inflammation and pain during acute gout attacks and long-term management to reduce serum urate levels and mitigate the risk of future attacks. Addressing inflammation and pain during acute attacks is often complicated by various factors, including underlying health conditions commonly associated with gout, such as hypertension, chronic kidney disease, cardiovascular disease, and diabetes mellitus. Moreover, gout patients are frequently older and have multiple coexisting health issues, necessitating complex medication regimens. Given the rising prevalence of gout and its associated comorbidities, there's a growing demand for improved treatment options. While existing treatments effectively manage gout in some patients, a significant portion, particularly those with comorbidities, face contraindications to these treatments and require alternative approaches. Innovative medications are required to enhance gout treatment, especially for individuals with concurrent health conditions. These considerations underscore the importance of reviewing both monotherapy and combination therapy approaches for acute gout treatment.
Competing Interests: The authors have declared that no competing interests exist.
(Copyright © 2023, Okobi et al.)
References: J Pharm Pract. 2017 Jan 1;:897190017734427. (PMID: 28980503)
Arthritis Rheum. 2009 Jul 15;61(7):885-92. (PMID: 19565556)
Rheumatology (Oxford). 2017 Dec 1;56(12):2170-2178. (PMID: 29029210)
Arthritis Res Ther. 2011 Mar 03;13(2):R39. (PMID: 21371293)
Postgrad Med. 2016 Sep;128(7):706-15. (PMID: 27558643)
Arthritis Rheum. 2010 Apr;62(4):1060-8. (PMID: 20131255)
Ann Rheum Dis. 2017 Jan;76(1):29-42. (PMID: 27457514)
Arthritis Res Ther. 2019 Jan 7;21(1):8. (PMID: 30616614)
Arthritis Rheum. 2011 Oct;63(10):3136-41. (PMID: 21800283)
JAMA. 2011 Aug 17;306(7):711-20. (PMID: 21846852)
Arthritis Res Ther. 2010;12(2):R63. (PMID: 20370912)
Ann Rheum Dis. 2012 Nov;71(11):1765-70. (PMID: 22863577)
NEJM Evid. 2022 Mar;1(3):. (PMID: 35434725)
Drugs Aging. 2017 May;34(5):401-410. (PMID: 28425024)
Drug Des Devel Ther. 2015 Jul 02;9:3423-34. (PMID: 26170627)
N Engl J Med. 2005 Dec 8;353(23):2450-61. (PMID: 16339094)
Arthritis Care Res (Hoboken). 2011 Jan;63(1):102-10. (PMID: 20824805)
Clin Rheumatol. 2019 Dec;38(12):3521-3528. (PMID: 31420811)
Arthritis Rheumatol. 2017 Jan;69(1):203-212. (PMID: 27564409)
Arthritis Rheumatol. 2016 Oct;68 Suppl 10:1-4550. (PMID: 27870508)
J Med Econ. 2020 Aug;23(8):838-847. (PMID: 32301360)
Minerva Med. 2017 Aug;108(4):341-349. (PMID: 28677361)
Drug Des Devel Ther. 2017 Oct 24;11:3077-3081. (PMID: 29123379)
Eur J Prev Cardiol. 2015 Mar;22(3):335-43. (PMID: 24281251)
Arthritis Care Res (Hoboken). 2012 Oct;64(10):1431-46. (PMID: 23024028)
PLoS One. 2022 Jan 28;17(1):e0261940. (PMID: 35089941)
P T. 2014 Oct;39(10):695-715. (PMID: 25336865)
Arch Intern Med. 1991 Apr;151(4):726-32. (PMID: 2012455)
Nutrients. 2020 Dec 10;12(12):. (PMID: 33322063)
Cureus. 2023 May 25;15(5):e39469. (PMID: 37362507)
Ann Intern Med. 2005 Oct 4;143(7):499-516. (PMID: 16204163)
Arthritis Rheumatol. 2017 Sep;69(9):1903-1913. (PMID: 28597604)
Clin Rheumatol. 2021 Feb;40(2):683-692. (PMID: 32654080)
Arthritis Care Res (Hoboken). 2013 Apr;65(4):571-7. (PMID: 22949176)
Clin Rheumatol. 2020 Nov;39(11):3287-3294. (PMID: 32418037)
Ann Rheum Dis. 2016 Jun;75(6):1074-80. (PMID: 26742777)
Ann Rheum Dis. 2012 Sep;71(9):1490-5. (PMID: 22440822)
فهرسة مساهمة: Keywords: acute gout; allopurinal monotherapy; lesinurad and allopurinal combination therapy; uricosuric; xanthine oxidase inhibitor
تواريخ الأحداث: Date Created: 20231016 Latest Revision: 20231020
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10568651
DOI: 10.7759/cureus.45087
PMID: 37842401
قاعدة البيانات: MEDLINE
الوصف
تدمد:2168-8184
DOI:10.7759/cureus.45087